Hot Movers: Novartis AG (NYSE:NVS), IMAX Corporation (NYSE:IMAX), ImmunoGen (NASDAQ:IMGN), bluebird bio (NASDAQ:BLUE), Randgold Resources (NASDAQ:GOLD)

Technology Stocks News 8

Novartis AG (ADR) (NYSE:NVS) announced today the submission of a Biologic License Application (BLA) to the US Food and Drug Administration (FDA) for marketing approval for the use of Bexsero® (Multicomponent Meningococcal Group B Vaccine [recombinant, adsorbed]) to help protect against invasive meningococcal disease caused by serogroup B (meningitis B) in adolescents and young adults from 10 years through 25 years of age. Novartis AG (ADR) (NYSE:NVS) stock performance was 1.18% in last session and finished the day at $90.39. Traded volume was 972.40K shares in the last session and the average volume of the stock remained 1.77million shares. The beta of the stock remained 0.61.

IMAX Corporation (USA) (NYSE:IMAX) shares rose Monday after the large-screen movie company announced a $150 million stock buyback program.  The company said the program – slated to run up to three years – reflects its strong financial position and positive expectations for its future cash position as well as its focus on returning value to shareholders. IMAX Corporation (USA) (NYSE:IMAX) rose 3.22 percent to $27.85 Monday on volume of 778.50K shares. The intra-day range of the stock was $27.40 to $28.00. IMAX Corporation (USA) (NYSE:IMAX) has a market capitalization of $1.90billion.

Immunogen, Inc. (NASDAQ:IMGN) disclosed for the first time preclinical data for IMGN779. The data were presented at the 19th Congress of the European Hematology Association (EHA) meeting in Milan, Italy (abstract# P802). IMGN779 is a novel, CD33-targeting, DNA-alkylating ADC that is a potential treatment for acute myeloid leukemia (AML). ImmunoGen, Inc. (NASDAQ:IMGN)’s stock on June 16, 2014 reported a increase of 0.23% to the closing price of $13.29. Its fifty two weeks range is $10.69 -$20.25. The total market capitalization recorded $1.14billion. The overall volume in the last trading session was 512.40K shares. In its share capital, IMGN has 85.81million outstanding shares.

bluebird bio, Inc. (NASDAQ:BLUE) released initial positive clinical data from its HGB-205 clinical study of its LentiGlobin BB305 product candidate in beta-thalassemia major subjects at the 19th Annual Congress of the European Hematology Association (EHA) in Milan, Italy. On Monday, shares of bluebird bio Inc (NASDAQ:BLUE) advanced 32.08% to close the day at $34.46. Company return on investment (ROI) is -16.40% and its monthly performance is recorded as 40.54%. bluebird bio Inc (NASDAQ:BLUE) quarterly revenue growth is 26.69%.

Randgold Resources Ltd. (NASDAQ:GOLD)’s stock had its “overweight” rating reiterated by analysts at Barclays in a research report issued to clients and investors on Monday. Randgold Resources Ltd. (ADR) (NASDAQ:GOLD) stock performance was 1.05% in last session and finished the day at $78.32. Traded volume was 6,800.00million shares in the last session and the average volume of the stock remained 534.95K shares. The beta of the stock remained 0.45.

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone